Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 2, 2016
Grant Date -
Nov 18, 2010
app pub date -
Oct 3, 2008
filing date -
Oct 5, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides methods and compositions comprising highly specific and highly effective antibodies that specifically recognize and bind to specific epitopes from a range of amyloid-beta proteins. The antibodies of the present invention are particularly useful for the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system, particularly those ocular diseases associated with amyloid-beta-related pathological abnormalities/changes in the tissues of the visual system.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully